Live Chat

Trade Vir Biotechnology VIR

Sell
 Buy

VirBiotechnology live chart

5m 15m 30m 1h 4h 1d 1w

instrument_fundamentals

Weekly Search
Weekly
Daily
date Close change Change (%) instr__open High Low

instr__news

Webhose 2025 Feb 21, 10:20

Vir Biotechnology, Inc. (NASDAQ:VIR) Director George A. Scangos Sells 10,964 Shares

Vir Biotechnology Inc
Webhose 2025 Feb 20, 07:32

Vir Biotechnology (VIR) to Release Earnings on Thursday

Vir Biotechnology Inc
Webhose 2025 Feb 19, 22:05

Company Website: https://vir.bio SAN FRANCISCO -- (Busines

Vir Biotechnology Inc
Webhose 2025 Feb 16, 02:15

Vir Biotechnology, Inc. (NASDAQ:VIR) CAO Brent Sabatini Sells 1,562 Shares

Vir Biotechnology Inc
Webhose 2025 Feb 15, 08:35

Empowered Funds LLC Lowers Position in Vir Biotechnology, Inc. (NASDAQ:VIR)

Vir Biotechnology Inc
Webhose 2025 Feb 14, 00:00

Brent Sabatini - Insider Monkey

Vir Biotechnology Inc
Webhose 2025 Feb 13, 11:40

Analysts' Opinions Are Mixed on These Healthcare Stocks: Irhythm Technologies (IRTC), Vir Biotechnology (VIR) and Biogen (BIIB) | Markets Insider

Vir Biotechnology Inc
Webhose 2025 Feb 11, 00:00

Authority Investment Dhabi Abu - Insider Monkey

Vir Biotechnology Inc
Webhose 2025 Feb 10, 08:31

abrdn plc Invests $2.67 Million in Vir Biotechnology, Inc. (NASDAQ:VIR)

Vir Biotechnology Inc
Webhose 2025 Feb 07, 11:40

Vir Biotechnology, Inc. (NASDAQ:VIR) Receives Average Rating of "Moderate Buy" from Brokerages

Vir Biotechnology Inc
Webhose 2025 Feb 05, 10:45

After a year of 7.8% returns, Vir Biotechnology, Inc.'s (NASDAQ:VIR) share price drop last week may have less of an impact on institutional investors

Vir Biotechnology Inc
Webhose 2025 Feb 05, 07:36

HC Wainwright Has Negative Estimate for VIR FY2029 Earnings

Vir Biotechnology Inc
Webhose 2025 Feb 02, 16:39

Short Interest in Vir Biotechnology, Inc. (NASDAQ:VIR) Grows By 20.0%

Vir Biotechnology Inc
Webhose 2025 Feb 01, 13:17

HC Wainwright Reaffirms Buy Rating for Vir Biotechnology (NASDAQ:VIR)

Vir Biotechnology Inc
Webhose 2025 Jan 25, 21:12

Vir Biotechnology (NASDAQ:VIR) versus Bavarian Nordic A/S (OTCMKTS:BVNRY) Head to Head Analysis

Vir Biotechnology Inc

Latest news

Tommy Yap 2025 Feb 22, 16:00

Week Ahead: Australia Inflation and US Core PCE Price Index in Focus

Forex Indices
Why did stock market drop today due to Walmart's economic outlook.
Vanessa L 2025 Feb 21, 06:40

Why Did Stock Market Drop Today? Walmart’s Forecast Sparks Economic Concerns

Frances Wang 2025 Feb 20, 16:00

Shiba inu news: What is happening to Shiba Inu today?

Cryptocurrencies
Alvaro Ramos 2025 Feb 20, 16:00

Dow jones stock markets today: Dow falls 450 points

Indices
Frances Wang 2025 Feb 20, 16:00

Lucid stock news today: Is Lucid stock expected to go up?

Stocks
Frances Wang 2025 Feb 20, 16:00

Forex market update: US Dollar struggles on mixed data

Forex
Tommy Yap 2025 Feb 20, 16:00

Morning Note: Oil Prices Climb, UK Retail Sales Rise & U.S. PMI

Morning Note Oil
Space.Xia 2025 Feb 20, 16:00

Asian Markets Stagnate on Trade Fears; Alibaba Drives HK Surge

Info

Spread

0.07

Spread (%)

0.7330 %

Leverage

1:10

Overnight Interest Buy

-0.0597 %

Overnight Interest Sell

-0.0292 %

Currency

USD

Trading Hours

Markets closed

Monday

14:31 - 20:59

Tuesday

14:31-20:59

Wednesday

14:31-20:59

Thursday

14:31-20:59

Friday

14:31-20:59

instr__analysis_statistics

instr__open

---

instr__close

---

instr__52week_range

--- – ---

instr__market_cap

1317980416

instr__shares_outstand

137720000

instr__earnings_date

0000-00-00

instr__dividend_date

instr__ex_dividend_date

instr__forward_annual_dividend_rate

0

instr__forward_annual_dividend_yield

0

instr__eps

-3.93

instrument_learn_more

Vir Biotechnology Vir Biotechnology Inc
Vir Biotechnology, Inc., an immunology company, develops therapeutic products to treat and prevent serious infectious diseases. Its clinical development pipeline consists of product candidates targeting hepatitis delta virus (HDV), hepatitis B virus (HBV), and human immunodeficiency virus (HIV). The company's preclinical candidates include those targeting influenza A and B, coronavirus disease 2019, respiratory syncytial virus (RSV) and human metapneumovirus (MPV), and human papillomavirus (HPV). The company has grant agreements with Bill & Melinda Gates Foundation and National Institutes of Health; an option and license agreement with Brii Biosciences Limited; a collaboration and license agreement with Alnylam Pharmaceuticals, Inc.; license agreements with MedImmune, LLC; collaboration with WuXi Biologics (Hong Kong) Limited and Glaxo Wellcome UK Ltd.; and a collaborative research agreement with GlaxoSmithKline Biologicals S.A, as well as license agreement with Sanofi for three clinical-stage masked T-cell engagers (TCEs) and exclusive use of the protease-cleavable masking platform for oncology and infectious diseases. It also has a manufacturing agreement with Samsung Biologics Co.,Ltd. The company was incorporated in 2016 and is headquartered in San Francisco, California.

related_instruments

Asset
Sell
Buy
Change (%)

trade_now_btn

trade_now_btn

trade_now_btn

trade_now_btn
view_all_instruments
Trustpilot
Live Chat